JP2011525990A

JP2011525990A - Ｆｅｔアレイを用いて分子相互作用を検出するための方法および装置

Ｆｅｔアレイを用いて分子相互作用を検出するための方法および装置 Download PDF

Info

Publication number: JP2011525990A
Authority: JP; Japan
Prior art keywords: chemfet; array; field effect; effect transistor; sensitive field
Prior art date: 2008-06-26
Legal status : Pending

Application number

JP2011516308A

Other languages

English (en)

Japanese (ja)

Other versions

JP2011525990A5 (enExample

Inventor

ロスバーグ，ジョナサン，エム．

Original Assignee

ライフテクノロジーズコーポレーション

Priority date

2008-06-26

Filing date

2009-06-26

Publication date

2011-09-29

2009-06-26 Application filed by ライフテクノロジーズコーポレーション filed Critical ライフテクノロジーズコーポレーション

2011-09-29 Publication of JP2011525990A publication Critical patent/JP2011525990A/ja

2012-05-24 Publication of JP2011525990A5 publication Critical patent/JP2011525990A5/ja

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 288
238000003491 array Methods 0.000 title abstract description 126
230000004001 molecular interaction Effects 0.000 title description 2
239000012491 analyte Substances 0.000 claims abstract description 193
238000001514 detection method Methods 0.000 claims abstract description 49
150000007523 nucleic acids Chemical class 0.000 claims description 291
102000039446 nucleic acids Human genes 0.000 claims description 287
108020004707 nucleic acids Proteins 0.000 claims description 287
238000006243 chemical reaction Methods 0.000 claims description 199
210000004027 cell Anatomy 0.000 claims description 171
230000005669 field effect Effects 0.000 claims description 109
239000003795 chemical substances by application Substances 0.000 claims description 102
108090000623 proteins and genes Proteins 0.000 claims description 90
102000004169 proteins and genes Human genes 0.000 claims description 82
239000013043 chemical agent Substances 0.000 claims description 54
239000003124 biologic agent Substances 0.000 claims description 52
230000027455 binding Effects 0.000 claims description 51
239000000758 substrate Substances 0.000 claims description 46
239000002773 nucleotide Substances 0.000 claims description 43
125000003729 nucleotide group Chemical group 0.000 claims description 42
108020004414 DNA Proteins 0.000 claims description 41
102000005962 receptors Human genes 0.000 claims description 41
108020003175 receptors Proteins 0.000 claims description 41
102000004190 Enzymes Human genes 0.000 claims description 40
108090000790 Enzymes Proteins 0.000 claims description 40
230000003993 interaction Effects 0.000 claims description 35
238000012544 monitoring process Methods 0.000 claims description 29
238000001311 chemical methods and process Methods 0.000 claims description 20
238000004113 cell culture Methods 0.000 claims description 17
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 15
239000008280 blood Substances 0.000 claims description 13
210000004369 blood Anatomy 0.000 claims description 13
210000001175 cerebrospinal fluid Anatomy 0.000 claims description 13
239000002299 complementary DNA Substances 0.000 claims description 13
210000003296 saliva Anatomy 0.000 claims description 13
210000002700 urine Anatomy 0.000 claims description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
108091023037 Aptamer Proteins 0.000 claims description 11
210000004958 brain cell Anatomy 0.000 claims description 11
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 9
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 9
108091070501 miRNA Proteins 0.000 claims description 7
239000002679 microRNA Substances 0.000 claims description 7
206010028980 Neoplasm Diseases 0.000 claims description 6
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical group NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 6
239000000427 antigen Substances 0.000 claims description 6
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 6
241000894006 Bacteria Species 0.000 claims description 5
201000011510 cancer Diseases 0.000 claims description 5
239000005556 hormone Substances 0.000 claims description 5
229940088597 hormone Drugs 0.000 claims description 5
244000052769 pathogen Species 0.000 claims description 5
102000004316 Oxidoreductases Human genes 0.000 claims description 4
108090000854 Oxidoreductases Proteins 0.000 claims description 4
108091023040 Transcription factor Proteins 0.000 claims description 4
102000040945 Transcription factor Human genes 0.000 claims description 4
241000700605 Viruses Species 0.000 claims description 4
239000002532 enzyme inhibitor Substances 0.000 claims description 4
229940125532 enzyme inhibitor Drugs 0.000 claims description 4
230000001717 pathogenic effect Effects 0.000 claims description 4
102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 claims description 3
108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 claims description 3
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical group C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 3
244000045947 parasite Species 0.000 claims description 3
230000001404 mediated effect Effects 0.000 claims 1
238000013461 design Methods 0.000 abstract description 96
239000000126 substance Substances 0.000 abstract description 54
238000005259 measurement Methods 0.000 abstract description 49
230000008859 change Effects 0.000 abstract description 47
230000035945 sensitivity Effects 0.000 abstract description 40
238000012545 processing Methods 0.000 abstract description 36
238000005516 engineering process Methods 0.000 abstract description 20
230000031018 biological processes and functions Effects 0.000 abstract description 2
230000001737 promoting effect Effects 0.000 abstract description 2
239000010410 layer Substances 0.000 description 330
239000012530 fluid Substances 0.000 description 151
229910052751 metal Inorganic materials 0.000 description 118
239000002184 metal Substances 0.000 description 118
239000000523 sample Substances 0.000 description 116
230000008569 process Effects 0.000 description 106
238000002161 passivation Methods 0.000 description 100
239000000463 material Substances 0.000 description 95
150000002500 ions Chemical class 0.000 description 89
239000000243 solution Substances 0.000 description 84
238000004519 manufacturing process Methods 0.000 description 75
238000012163 sequencing technique Methods 0.000 description 74
235000018102 proteins Nutrition 0.000 description 71
239000011324 bead Substances 0.000 description 67
239000000872 buffer Substances 0.000 description 61
230000008878 coupling Effects 0.000 description 59
238000010168 coupling process Methods 0.000 description 59
238000005859 coupling reaction Methods 0.000 description 59
238000010586 diagram Methods 0.000 description 49
108091006146 Channels Proteins 0.000 description 43
239000011521 glass Substances 0.000 description 41
230000004044 response Effects 0.000 description 40
239000004065 semiconductor Substances 0.000 description 40
241000894007 species Species 0.000 description 40
238000007667 floating Methods 0.000 description 39
-1 hydrogen ions Chemical class 0.000 description 39
230000015572 biosynthetic process Effects 0.000 description 36
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 34
229910052710 silicon Inorganic materials 0.000 description 34
239000010703 silicon Substances 0.000 description 34
239000004020 conductor Substances 0.000 description 33
230000000694 effects Effects 0.000 description 33
229910052581 Si3N4 Inorganic materials 0.000 description 30
HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 30
150000001875 compounds Chemical class 0.000 description 29
229920003023 plastic Polymers 0.000 description 29
239000004033 plastic Substances 0.000 description 29
229920000642 polymer Polymers 0.000 description 29
239000011295 pitch Substances 0.000 description 28
239000001257 hydrogen Substances 0.000 description 27
229910052739 hydrogen Inorganic materials 0.000 description 27
238000003786 synthesis reaction Methods 0.000 description 27
230000006870 function Effects 0.000 description 26
125000005647 linker group Chemical group 0.000 description 24
239000003153 chemical reaction reagent Substances 0.000 description 22
230000002829 reductive effect Effects 0.000 description 22
239000007787 solid Substances 0.000 description 22
239000004205 dimethyl polysiloxane Substances 0.000 description 21
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 21
235000012431 wafers Nutrition 0.000 description 21
230000003321 amplification Effects 0.000 description 20
238000004458 analytical method Methods 0.000 description 20
238000000151 deposition Methods 0.000 description 20
238000003199 nucleic acid amplification method Methods 0.000 description 20
108090000765 processed proteins & peptides Proteins 0.000 description 20
238000005070 sampling Methods 0.000 description 20
239000003990 capacitor Substances 0.000 description 19
238000002493 microarray Methods 0.000 description 19
229920002120 photoresistant polymer Polymers 0.000 description 19
230000005855 radiation Effects 0.000 description 19
210000001519 tissue Anatomy 0.000 description 19
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
230000005540 biological transmission Effects 0.000 description 18
108091034117 Oligonucleotide Proteins 0.000 description 16
238000009396 hybridization Methods 0.000 description 16
229910021420 polycrystalline silicon Inorganic materials 0.000 description 16
238000013459 approach Methods 0.000 description 15
230000000295 complement effect Effects 0.000 description 15
230000008021 deposition Effects 0.000 description 15
229910044991 metal oxide Inorganic materials 0.000 description 15
238000003499 nucleic acid array Methods 0.000 description 15
239000000047 product Substances 0.000 description 15
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 14
239000007789 gas Substances 0.000 description 14
150000004706 metal oxides Chemical class 0.000 description 14
238000003498 protein array Methods 0.000 description 14
230000007704 transition Effects 0.000 description 14
230000000670 limiting effect Effects 0.000 description 12
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
230000014509 gene expression Effects 0.000 description 11
238000010348 incorporation Methods 0.000 description 11
239000007788 liquid Substances 0.000 description 11
238000001668 nucleic acid synthesis Methods 0.000 description 11
102000004196 processed proteins & peptides Human genes 0.000 description 11
238000012546 transfer Methods 0.000 description 11
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 11
150000001413 amino acids Chemical class 0.000 description 10
230000008901 benefit Effects 0.000 description 10
201000010099 disease Diseases 0.000 description 10
238000011065 in-situ storage Methods 0.000 description 10
238000001746 injection moulding Methods 0.000 description 10
230000004048 modification Effects 0.000 description 10
238000012986 modification Methods 0.000 description 10
238000012856 packing Methods 0.000 description 10
238000000206 photolithography Methods 0.000 description 10
239000011734 sodium Substances 0.000 description 10
230000001052 transient effect Effects 0.000 description 10
102000003960 Ligases Human genes 0.000 description 9
108090000364 Ligases Proteins 0.000 description 9
229910052782 aluminium Inorganic materials 0.000 description 9
238000000137 annealing Methods 0.000 description 9
239000011575 calcium Substances 0.000 description 9
229920005591 polysilicon Polymers 0.000 description 9
238000011160 research Methods 0.000 description 9
230000003068 static effect Effects 0.000 description 9
229910004298 SiO 2 Inorganic materials 0.000 description 8
239000002253 acid Substances 0.000 description 8
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 8
238000004140 cleaning Methods 0.000 description 8
238000012937 correction Methods 0.000 description 8
238000009792 diffusion process Methods 0.000 description 8
238000010494 dissociation reaction Methods 0.000 description 8
238000002347 injection Methods 0.000 description 8
239000007924 injection Substances 0.000 description 8
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 8
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
238000001712 DNA sequencing Methods 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
239000002131 composite material Substances 0.000 description 7
230000001419 dependent effect Effects 0.000 description 7
238000005530 etching Methods 0.000 description 7
230000004907 flux Effects 0.000 description 7
239000012634 fragment Substances 0.000 description 7
238000001459 lithography Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 7
BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 7
238000001020 plasma etching Methods 0.000 description 7
238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 7
239000000377 silicon dioxide Substances 0.000 description 7
235000012239 silicon dioxide Nutrition 0.000 description 7
239000004593 Epoxy Substances 0.000 description 6
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
229910052791 calcium Inorganic materials 0.000 description 6
229920002678 cellulose Polymers 0.000 description 6
230000006378 damage Effects 0.000 description 6
230000005593 dissociations Effects 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
150000004676 glycans Chemical class 0.000 description 6
GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 6
239000002555 ionophore Substances 0.000 description 6
230000000236 ionophoric effect Effects 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
238000002966 oligonucleotide array Methods 0.000 description 6
239000001301 oxygen Substances 0.000 description 6
229910052760 oxygen Inorganic materials 0.000 description 6
239000005360 phosphosilicate glass Substances 0.000 description 6
229920001282 polysaccharide Polymers 0.000 description 6
239000005017 polysaccharide Substances 0.000 description 6
229910052700 potassium Inorganic materials 0.000 description 6
239000011591 potassium Substances 0.000 description 6
238000006722 reduction reaction Methods 0.000 description 6
229910052709 silver Inorganic materials 0.000 description 6
239000004332 silver Substances 0.000 description 6
229910018072 Al 2 O 3 Inorganic materials 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 5
238000000018 DNA microarray Methods 0.000 description 5
239000004642 Polyimide Substances 0.000 description 5
230000002411 adverse Effects 0.000 description 5
150000001412 amines Chemical class 0.000 description 5
230000001588 bifunctional effect Effects 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
239000001913 cellulose Substances 0.000 description 5
239000000919 ceramic Substances 0.000 description 5
230000021615 conjugation Effects 0.000 description 5
238000002508 contact lithography Methods 0.000 description 5
150000002431 hydrogen Chemical class 0.000 description 5
238000003384 imaging method Methods 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
238000011068 loading method Methods 0.000 description 5
238000001465 metallisation Methods 0.000 description 5
239000000178 monomer Substances 0.000 description 5
230000001537 neural effect Effects 0.000 description 5
210000002569 neuron Anatomy 0.000 description 5
239000011368 organic material Substances 0.000 description 5
229920000515 polycarbonate Polymers 0.000 description 5
239000004417 polycarbonate Substances 0.000 description 5
229920001721 polyimide Polymers 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
230000009467 reduction Effects 0.000 description 5
230000002441 reversible effect Effects 0.000 description 5
150000003384 small molecules Chemical class 0.000 description 5
229910052708 sodium Inorganic materials 0.000 description 5
230000000638 stimulation Effects 0.000 description 5
229910001936 tantalum oxide Inorganic materials 0.000 description 5
238000012360 testing method Methods 0.000 description 5
125000003396 thiol group Chemical group [H]S* 0.000 description 5
238000011282 treatment Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
108091093037 Peptide nucleic acid Proteins 0.000 description 4
239000004743 Polypropylene Substances 0.000 description 4
229910021607 Silver chloride Inorganic materials 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
239000000853 adhesive Substances 0.000 description 4
230000001070 adhesive effect Effects 0.000 description 4
125000000266 alpha-aminoacyl group Chemical group 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
239000011616 biotin Substances 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
150000001768 cations Chemical class 0.000 description 4
230000001054 cortical effect Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
239000003989 dielectric material Substances 0.000 description 4
230000007613 environmental effect Effects 0.000 description 4
239000010408 film Substances 0.000 description 4
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
229910052737 gold Inorganic materials 0.000 description 4
239000010931 gold Substances 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
230000006872 improvement Effects 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
239000003446 ligand Substances 0.000 description 4
108020004999 messenger RNA Proteins 0.000 description 4
238000004377 microelectronic Methods 0.000 description 4
150000004767 nitrides Chemical class 0.000 description 4
230000003287 optical effect Effects 0.000 description 4
238000005457 optimization Methods 0.000 description 4
230000003071 parasitic effect Effects 0.000 description 4
238000000059 patterning Methods 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
229920001296 polysiloxane Polymers 0.000 description 4
230000033764 rhythmic process Effects 0.000 description 4
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
238000005549 size reduction Methods 0.000 description 4
238000000992 sputter etching Methods 0.000 description 4
LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 4
239000010409 thin film Substances 0.000 description 4
238000005406 washing Methods 0.000 description 4
239000002699 waste material Substances 0.000 description 4
229920002307 Dextran Polymers 0.000 description 3
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
102000003992 Peroxidases Human genes 0.000 description 3
229920002732 Polyanhydride Polymers 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
239000004793 Polystyrene Substances 0.000 description 3
108020004422 Riboswitch Proteins 0.000 description 3
229920001486 SU-8 photoresist Polymers 0.000 description 3
108020004459 Small interfering RNA Proteins 0.000 description 3
108010090804 Streptavidin Proteins 0.000 description 3
239000000370 acceptor Substances 0.000 description 3
230000035508 accumulation Effects 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
230000000712 assembly Effects 0.000 description 3
238000000429 assembly Methods 0.000 description 3
230000004888 barrier function Effects 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
229920001400 block copolymer Polymers 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
230000004098 cellular respiration Effects 0.000 description 3
239000002800 charge carrier Substances 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
230000009849 deactivation Effects 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
238000010195 expression analysis Methods 0.000 description 3
230000004438 eyesight Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
230000009931 harmful effect Effects 0.000 description 3
239000007943 implant Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
238000009434 installation Methods 0.000 description 3
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
238000002955 isolation Methods 0.000 description 3
238000004518 low pressure chemical vapour deposition Methods 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
238000000691 measurement method Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
230000000116 mitigating effect Effects 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
238000007899 nucleic acid hybridization Methods 0.000 description 3
238000001139 pH measurement Methods 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
230000035479 physiological effects, processes and functions Effects 0.000 description 3
229920002223 polystyrene Polymers 0.000 description 3
229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
229910052814 silicon oxide Inorganic materials 0.000 description 3
239000002356 single layer Substances 0.000 description 3
229910001220 stainless steel Inorganic materials 0.000 description 3
239000010935 stainless steel Substances 0.000 description 3
238000003860 storage Methods 0.000 description 3
XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 3
238000012876 topography Methods 0.000 description 3
239000001226 triphosphate Substances 0.000 description 3
235000011178 triphosphate Nutrition 0.000 description 3
238000012800 visualization Methods 0.000 description 3
230000029663 wound healing Effects 0.000 description 3
WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
108090001008 Avidin Proteins 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
239000001856 Ethyl cellulose Substances 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
229910002651 NO3 Inorganic materials 0.000 description 2
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
108091005461 Nucleic proteins Proteins 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
229920001305 Poly(isodecyl(meth)acrylate) Polymers 0.000 description 2
229920002319 Poly(methyl acrylate) Polymers 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102000044126 RNA-Binding Proteins Human genes 0.000 description 2
108700020471 RNA-Binding Proteins Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
239000007997 Tricine buffer Substances 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
108010067973 Valinomycin Proteins 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000008186 active pharmaceutical agent Substances 0.000 description 2
239000013543 active substance Substances 0.000 description 2
229940072056 alginate Drugs 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
238000003556 assay Methods 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000019522 cellular metabolic process Effects 0.000 description 2
230000036755 cellular response Effects 0.000 description 2
229910052804 chromium Inorganic materials 0.000 description 2
239000011651 chromium Substances 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
238000004891 communication Methods 0.000 description 2
230000006854 communication Effects 0.000 description 2
FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000012864 cross contamination Methods 0.000 description 2
238000013481 data capture Methods 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000005137 deposition process Methods 0.000 description 2
KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
230000005684 electric field Effects 0.000 description 2
238000000313 electron-beam-induced deposition Methods 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
229920001249 ethyl cellulose Polymers 0.000 description 2
235000019325 ethyl cellulose Nutrition 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000013467 fragmentation Methods 0.000 description 2
238000006062 fragmentation reaction Methods 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
230000034659 glycolysis Effects 0.000 description 2
230000035876 healing Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229910001385 heavy metal Inorganic materials 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000007641 inkjet printing Methods 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
239000011147 inorganic material Substances 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
229910052742 iron Inorganic materials 0.000 description 2
238000005304 joining Methods 0.000 description 2
238000002372 labelling Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000004816 latex Substances 0.000 description 2
229920000126 latex Polymers 0.000 description 2
238000002386 leaching Methods 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
230000000873 masking effect Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
230000035772 mutation Effects 0.000 description 2
239000002581 neurotoxin Substances 0.000 description 2
231100000618 neurotoxin Toxicity 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
230000010355 oscillation Effects 0.000 description 2
230000010627 oxidative phosphorylation Effects 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 2
229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 2
229920000212 poly(isobutyl acrylate) Polymers 0.000 description 2
229920000205 poly(isobutyl methacrylate) Polymers 0.000 description 2
229920000196 poly(lauryl methacrylate) Polymers 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920000184 poly(octadecyl acrylate) Polymers 0.000 description 2
229920000129 polyhexylmethacrylate Polymers 0.000 description 2
229920000197 polyisopropyl acrylate Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
102000054765 polymorphisms of proteins Human genes 0.000 description 2
229920000182 polyphenyl methacrylate Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
229920002635 polyurethane Polymers 0.000 description 2
239000004814 polyurethane Substances 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
229910001414 potassium ion Inorganic materials 0.000 description 2
238000007639 printing Methods 0.000 description 2
238000005086 pumping Methods 0.000 description 2
230000002207 retinal effect Effects 0.000 description 2
238000005096 rolling process Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 2
229910001415 sodium ion Inorganic materials 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
230000000153 supplemental effect Effects 0.000 description 2
238000010189 synthetic method Methods 0.000 description 2
PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 2
229910001887 tin oxide Inorganic materials 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
230000032258 transport Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
229910052721 tungsten Inorganic materials 0.000 description 2
239000010937 tungsten Substances 0.000 description 2
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 2
238000007704 wet chemistry method Methods 0.000 description 2
XUDGDVPXDYGCTG-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[2-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethylsulfonyl]ethyl carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCCS(=O)(=O)CCOC(=O)ON1C(=O)CCC1=O XUDGDVPXDYGCTG-UHFFFAOYSA-N 0.000 description 1
JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
MWOGMBZGFFZBMK-LJZWMIMPSA-N (2s)-2-[[(2s)-2-[[2-[[(2s,3s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWOGMBZGFFZBMK-LJZWMIMPSA-N 0.000 description 1
0 **(*)=Nc(cc1)ccc1[N+]([O-])=O Chemical compound **(*)=Nc(cc1)ccc1[N+]([O-])=O 0.000 description 1
AASYSXRGODIQGY-UHFFFAOYSA-N 1-[1-(2,5-dioxopyrrol-1-yl)hexyl]pyrrole-2,5-dione Chemical group O=C1C=CC(=O)N1C(CCCCC)N1C(=O)C=CC1=O AASYSXRGODIQGY-UHFFFAOYSA-N 0.000 description 1
KXZQYLBVMZGIKC-UHFFFAOYSA-N 1-pyridin-2-yl-n-(pyridin-2-ylmethyl)methanamine Chemical compound C=1C=CC=NC=1CNCC1=CC=CC=N1 KXZQYLBVMZGIKC-UHFFFAOYSA-N 0.000 description 1
RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
VGFIFGDQCGDVTI-UHFFFAOYSA-N 2,3-bis[[bis(pyridin-2-ylmethyl)amino]methyl]-4-naphthalen-1-ylphenol Chemical compound C=1C=CC=NC=1CN(CC=1N=CC=CC=1)CC=1C(O)=CC=C(C=2C3=CC=CC=C3C=CC=2)C=1CN(CC=1N=CC=CC=1)CC1=CC=CC=N1 VGFIFGDQCGDVTI-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
ZMRMMAOBSFSXLN-UHFFFAOYSA-N 4-[4-(2,5-dioxopyrrol-1-yl)phenyl]butanehydrazide Chemical compound C1=CC(CCCC(=O)NN)=CC=C1N1C(=O)C=CC1=O ZMRMMAOBSFSXLN-UHFFFAOYSA-N 0.000 description 1
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 1
229920000178 Acrylic resin Polymers 0.000 description 1
239000004925 Acrylic resin Substances 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
101100328892 Arabidopsis thaliana COL4 gene Proteins 0.000 description 1
241001598984 Bromius obscurus Species 0.000 description 1
101100328886 Caenorhabditis elegans col-2 gene Proteins 0.000 description 1
101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 1
229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
229920002284 Cellulose triacetate Polymers 0.000 description 1
208000031976 Channelopathies Diseases 0.000 description 1
108010035848 Channelrhodopsins Proteins 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
UDSFAEKRVUSQDD-UHFFFAOYSA-N Dimethyl adipate Chemical compound COC(=O)CCCCC(=O)OC UDSFAEKRVUSQDD-UHFFFAOYSA-N 0.000 description 1
101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
206010071602 Genetic polymorphism Diseases 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
108010026389 Gramicidin Proteins 0.000 description 1
108010050754 Halorhodopsins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
108010058683 Immobilized Proteins Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108090000862 Ion Channels Proteins 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
108091092878 Microsatellite Proteins 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
229930191564 Monensin Natural products 0.000 description 1
GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
102000010175 Opsin Human genes 0.000 description 1
108050001704 Opsin Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
241000269908 Platichthys flesus Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
229920001283 Polyalkylene terephthalate Polymers 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000183024 Populus tremula Species 0.000 description 1
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
101150044917 Prl3b1 gene Proteins 0.000 description 1
102000009609 Pyrophosphatases Human genes 0.000 description 1
108010009413 Pyrophosphatases Proteins 0.000 description 1
101150111584 RHOA gene Proteins 0.000 description 1
108091036333 Rapid DNA Proteins 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
239000004189 Salinomycin Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
229910006404 SnO 2 Inorganic materials 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
101100237842 Xenopus laevis mmp18 gene Proteins 0.000 description 1
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 1
NYEWVWNUXGFPNY-UHFFFAOYSA-N [amino(benzoyl)amino]-diazonioazanide Chemical compound [N-]=[N+]=NN(N)C(=O)C1=CC=CC=C1 NYEWVWNUXGFPNY-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
229920006322 acrylamide copolymer Polymers 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
238000007792 addition Methods 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229920013820 alkyl cellulose Polymers 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
238000000637 aluminium metallisation Methods 0.000 description 1
229940064734 aminobenzoate Drugs 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
239000006117 anti-reflective coating Substances 0.000 description 1
230000009830 antibody antigen interaction Effects 0.000 description 1
230000009833 antibody interaction Effects 0.000 description 1
230000009831 antigen interaction Effects 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
238000013475 authorization Methods 0.000 description 1
230000007940 bacterial gene expression Effects 0.000 description 1
229910001422 barium ion Inorganic materials 0.000 description 1
229910001423 beryllium ion Inorganic materials 0.000 description 1
230000003851 biochemical process Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
108091006004 biotinylated proteins Proteins 0.000 description 1
NXVYSVARUKNFNF-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) 2,3-dihydroxybutanedioate Chemical compound O=C1CCC(=O)N1OC(=O)C(O)C(O)C(=O)ON1C(=O)CCC1=O NXVYSVARUKNFNF-UHFFFAOYSA-N 0.000 description 1
VYLDEYYOISNGST-UHFFFAOYSA-N bissulfosuccinimidyl suberate Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)C(S(O)(=O)=O)CC1=O VYLDEYYOISNGST-UHFFFAOYSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000746 body region Anatomy 0.000 description 1
230000003925 brain function Effects 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
239000008364 bulk solution Substances 0.000 description 1
230000009172 bursting Effects 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
239000001273 butane Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000002041 carbon nanotube Substances 0.000 description 1
229910021393 carbon nanotube Inorganic materials 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
229920006217 cellulose acetate butyrate Polymers 0.000 description 1
229940081734 cellulose acetate phthalate Drugs 0.000 description 1
229920003086 cellulose ether Polymers 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
239000007806 chemical reaction intermediate Substances 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
238000005229 chemical vapour deposition Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
210000000860 cochlear nerve Anatomy 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000000512 collagen gel Substances 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
229940125904 compound 1 Drugs 0.000 description 1
229940125782 compound 2 Drugs 0.000 description 1
229940126214 compound 3 Drugs 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000007585 cortical function Effects 0.000 description 1
NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
231100000895 deafness Toxicity 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000009795 derivation Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
230000029087 digestion Effects 0.000 description 1
ILKCDNKCNSNFMP-UHFFFAOYSA-N dimethyl octanediimidate;hydron;dichloride Chemical compound Cl.Cl.COC(=N)CCCCCCC(=N)OC ILKCDNKCNSNFMP-UHFFFAOYSA-N 0.000 description 1
LRPQMNYCTSPGCX-UHFFFAOYSA-N dimethyl pimelimidate Chemical compound COC(=N)CCCCCC(=N)OC LRPQMNYCTSPGCX-UHFFFAOYSA-N 0.000 description 1
229910001873 dinitrogen Inorganic materials 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
238000010017 direct printing Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940000406 drug candidate Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
238000002593 electrical impedance tomography Methods 0.000 description 1
210000000620 electrically active cell Anatomy 0.000 description 1
230000005611 electricity Effects 0.000 description 1
230000005518 electrochemistry Effects 0.000 description 1
238000007772 electroless plating Methods 0.000 description 1
238000005868 electrolysis reaction Methods 0.000 description 1
238000005566 electron beam evaporation Methods 0.000 description 1
238000004049 embossing Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
238000011066 ex-situ storage Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
238000013213 extrapolation Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000012921 fluorescence analysis Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000012100 gene-based analysis Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
102000054766 genetic haplotypes Human genes 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 description 1
229960004905 gramicidin Drugs 0.000 description 1
ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
230000017525 heat dissipation Effects 0.000 description 1
238000012165 high-throughput sequencing Methods 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000033444 hydroxylation Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
239000011229 interlayer Substances 0.000 description 1
230000012105 intracellular pH reduction Effects 0.000 description 1
238000000869 ion-assisted deposition Methods 0.000 description 1
238000010884 ion-beam technique Methods 0.000 description 1
PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
238000011901 isothermal amplification Methods 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
238000012804 iterative process Methods 0.000 description 1
238000003368 label free method Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
238000012886 linear function Methods 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000001755 magnetron sputter deposition Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000025350 membrane depolarization involved in regulation of action potential Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
238000005272 metallurgy Methods 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
125000005397 methacrylic acid ester group Chemical group 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000813 microcontact printing Methods 0.000 description 1
238000003801 milling Methods 0.000 description 1
239000012778 molding material Substances 0.000 description 1
229960005358 monensin Drugs 0.000 description 1
GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
238000000465 moulding Methods 0.000 description 1
RQUGVTLRYOAFLV-UHFFFAOYSA-N n-(4-aminobutyl)-4-azido-2-hydroxybenzamide Chemical compound NCCCCNC(=O)C1=CC=C(N=[N+]=[N-])C=C1O RQUGVTLRYOAFLV-UHFFFAOYSA-N 0.000 description 1
IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
238000002663 nebulization Methods 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
230000003767 neural control Effects 0.000 description 1
230000009251 neurologic dysfunction Effects 0.000 description 1
208000015015 neurological dysfunction Diseases 0.000 description 1
230000004751 neurological system process Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 description 1
108091008104 nucleic acid aptamers Proteins 0.000 description 1
238000003203 nucleic acid sequencing method Methods 0.000 description 1
235000003715 nutritional status Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229960000988 nystatin Drugs 0.000 description 1
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
238000013021 overheating Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
238000012858 packaging process Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920000233 poly(alkylene oxides) Polymers 0.000 description 1
229920000111 poly(butyric acid) Polymers 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
239000002745 poly(ortho ester) Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
229920001281 polyalkylene Polymers 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001610 polycaprolactone Polymers 0.000 description 1
239000004632 polycaprolactone Substances 0.000 description 1
229920006149 polyester-amide block copolymer Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920000128 polypyrrole Polymers 0.000 description 1
229920001290 polyvinyl ester Polymers 0.000 description 1
229920001289 polyvinyl ether Polymers 0.000 description 1
229920001291 polyvinyl halide Polymers 0.000 description 1
238000012805 post-processing Methods 0.000 description 1
244000144977 poultry Species 0.000 description 1
238000003825 pressing Methods 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
229940080818 propionamide Drugs 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000011155 quantitative monitoring Methods 0.000 description 1
238000001552 radio frequency sputter deposition Methods 0.000 description 1
238000011897 real-time detection Methods 0.000 description 1
231100000812 repeated exposure Toxicity 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000019254 respiratory burst Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000005060 rubber Substances 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
229960001548 salinomycin Drugs 0.000 description 1
235000019378 salinomycin Nutrition 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
239000002094 self assembled monolayer Substances 0.000 description 1
239000013545 self-assembled monolayer Substances 0.000 description 1
238000001338 self-assembly Methods 0.000 description 1
238000011451 sequencing strategy Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
238000010008 shearing Methods 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
238000003373 small molecule array Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
ZAPNXDUFCQIHFS-UHFFFAOYSA-M sodium;2,5-dioxo-1-[6-[3-(pyridin-2-yldisulfanyl)propanoylamino]hexanoyloxy]pyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCNC(=O)CCSSC1=CC=CC=N1 ZAPNXDUFCQIHFS-UHFFFAOYSA-M 0.000 description 1
239000008279 sol Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
238000012732 spatial analysis Methods 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
238000009987 spinning Methods 0.000 description 1
239000010959 steel Substances 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000001847 surface plasmon resonance imaging Methods 0.000 description 1
230000009534 synaptic inhibition Effects 0.000 description 1
210000002504 synaptic vesicle Anatomy 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012731 temporal analysis Methods 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000002207 thermal evaporation Methods 0.000 description 1
150000003544 thiamines Chemical class 0.000 description 1
238000007736 thin film deposition technique Methods 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
238000003325 tomography Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
229910001930 tungsten oxide Inorganic materials 0.000 description 1
108010052768 tyrosyl-isoleucyl-glycyl-seryl-arginine Proteins 0.000 description 1
229940005605 valeric acid Drugs 0.000 description 1
229910001935 vanadium oxide Inorganic materials 0.000 description 1
229920006163 vinyl copolymer Polymers 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
230000016776 visual perception Effects 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1